Electrical Ventricular Remodeling in Dilated Cardiomyopathy
Christine Mages(Heidelberg University), Dierk Thomas(Heidelberg University), Heike Gampp(Heidelberg University), Florian André(Heidelberg University), Pascal Syren(Heidelberg University), Norbert Frey(Heidelberg University), Patrick Lugenbiel(Heidelberg University), Ann‐Kathrin Rahm(Heidelberg University)
Cited by 20
Related Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation
|Circulation|2020|502
RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction
|Cardiovascular Research|2014|316
Upregulation of K <sub>2P</sub> 3.1 K <sup>+</sup> Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation
|Circulation|2015|195
U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis
|Experimental & Molecular Medicine|2013|172